Literature DB >> 17851256

Ligation of Toll-like receptor 3 differentially regulates M2 and M3 muscarinic receptor expression and function in human airway smooth muscle cells.

Hirotaka Morishima1, Keiichi Kajiwara, Kazuo Akiyama, Yukiyoshi Yanagihara.   

Abstract

BACKGROUND: Viral infection causes asthma exacerbations and airway hyperreactivity. Toll-like receptor 3 (TLR3) recognizes double-stranded RNA (dsRNA) of viral or synthetic origin in a fashion different from protein kinase R (PKR). The aim of this study was to examine the expression and function of TLR3 in human airway smooth muscle (ASM) cells.
METHODS: Expression of TLR3 and muscarinic receptor (MR), histamine receptor (HR), and cysteinyl leukotriene receptor (CysLTR) subtypes was analyzed by quantitative real-time PCR, flow cytometry, or Western blotting. It was assessed whether ASM cells respond to polyinosinic-polycytidylic acid (poly I:C), a synthetic analog of dsRNA, with alterations in M2R, M3R, H1R, and CysLT1R expression. The function of these subtypes was evaluated by cholinergic regulation of forskolin-stimulated cyclic AMP accumulation or by mobilization of intracellular calcium upon stimulation.
RESULTS: ASM cells expressed TLR3 and PKR, and intracellular TLR3 expression was demonstrated. Poly I:C caused decreased M2R and increased M3R expression, without affecting H1R and CysLT1R expression. Poly I:C-treated cells showed decreased cholinergic inhibition of forskolin-stimulated cyclic AMP accumulation and enhanced calcium flux in response to acetylcholine, but not to histamine and LTD4. These modulating effects of poly I:C were reversed by chloroquine, but not by 2-aminopurine.
CONCLUSIONS: The data indicate that poly I:C internalized by ASM cells differentially regulates M2R and M3R expression and function by interacting with TLR3 rather than with PKR, suggesting that these changes may contribute to airway hyperreactivity. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17851256     DOI: 10.1159/000108141

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  6 in total

1.  Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice.

Authors:  Na Zang; Xiaohong Xie; Yu Deng; Shengde Wu; Lijia Wang; Caijing Peng; Simin Li; Ke Ni; Yan Luo; Enmei Liu
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Ethanol attenuates contraction of primary cultured rat airway smooth muscle cells.

Authors:  Peter J Oldenburg; Todd A Wyatt; Joseph H Sisson
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-20       Impact factor: 6.914

3.  Systems pharmacology models can be used to understand complex pharmacokinetic-pharmacodynamic behavior: an example using 5-lipoxygenase inhibitors.

Authors:  O Demin; T Karelina; D Svetlichniy; E Metelkin; G Speshilov; O Demin; D Fairman; P H van der Graaf; B M Agoram
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-09-11

Review 4.  Penehyclidine hydrochloride: a potential drug for treating COPD by attenuating Toll-like receptors.

Authors:  Hong-Tao Xiao; Zhi Liao; Rong-Sheng Tong
Journal:  Drug Des Devel Ther       Date:  2012-11-01       Impact factor: 4.162

5.  Innate immune receptors in human airway smooth muscle cells: activation by TLR1/2, TLR3, TLR4, TLR7 and NOD1 agonists.

Authors:  Anne Månsson Kvarnhammar; Lotta Tengroth; Mikael Adner; Lars-Olaf Cardell
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

6.  Toll-like receptor ligands LPS and poly (I:C) exacerbate airway hyperresponsiveness in a model of airway allergy in mice, independently of inflammation.

Authors:  Magnus Starkhammar; Olivia Larsson; Susanna Kumlien Georén; Marina Leino; Sven-Erik Dahlén; Mikael Adner; Lars-Olaf Cardell
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.